Odds SpaceX Merger with Tesla Climb as Stocks Rally Higher
Rising private valuations for SpaceX are fueling chatter about a Tesla takeover. Market participants say the odds spa...
What Moves Stock Indices
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,624 articlesIBM: Should Investors Crash or Stay Put in 2026 and Beyond?
A 25 percent drop often triggers fear and temptation to buy the dip. This article breaks down IBM s recent results, t...
YieldMax’s PYPY Riding Down Warns on Income Outlook 2026
PayPal’s plunging stock drags down YieldMax’s PYPY, with weekly distributions shrinking as Q4 2025 missed expectation...
This News From NVIDIA Could Shift Stocks Into Overdrive
NVIDIA’s latest announcements are stirring chatter about AI-driven growth and new catalysts. Here’s what investors sh...
Reasons Bristol Myers Squibb Stock: 3 Key Arguments
Want to know if Bristol Myers Squibb is worth a spot in your portfolio? This deep dive highlights three core reasons ...
Stock Fraction Nvidia's Size: Where AMD and Nvidia Diverge
AMD and Nvidia both ride the AI wave, but their scales and strategies differ. This deep dive shows why the stock frac...
Super Micro Faced Probes: Can This AI Stock Survive 2026?
Regulatory headlines have a way of rattling investors, especially in high-growth tech sectors. This article dives int...
Stock Market Still Trading Near Highs: Hidden Risk
Even as major indices hover near record highs, investors may overlook a key risk. This guide explains the danger and ...
This Stock Will Dominate the Second Half of 2026 Markets
Alphabet is trading in the mid‑$300s as AI monetization and cloud expansion threaten to carry momentum into the secon...
Qualcomm Down 2026 Just: Buyback Signals or Warning?
Qualcomm is navigating a tough start to 2026. A memory crunch, potential shifts with Apple, and a large buyback are m...
Broadcom's Revenue Just Soared: AI Demand and Stock
Broadcom is riding a powerful AI wave, with revenue in key AI-adjacent areas jumping. Yet the stock moved lower after...
Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status